Peptide Publications Archive
Showing items in Drug Discovery · Clear filter
GLP-1s Block Amyloid
Limbocker Lab
Millions of people already take GLP-1 receptor agonists for diabetes and weight loss, but whether these drugs directly interfere with the molecular machinery of Alzheimer's …
Profiling Transpeptidase Targets
Pires Lab
Tuberculosis kills more than a million people each year, yet the enzymes that stitch together its cell wall remain poorly understood and difficult to target. …
Paired Library Pursuit
Suga Lab
Most peptide discovery platforms find one binder at a time. A new library-vs-library extension of the RaPID system pairs two 10¹²-member macrocyclic peptide libraries and …
Hydrazino Turn Hunters
Suga Lab
α-Hydrazino acids have long tantalized peptide chemists with their turn-inducing and protease-resisting properties, yet no one had managed to screen them de novo against protein …
Tuning Incretin Balance
Kumar Lab
A single chemical edit at the N-terminus of a GLP-1/GIP/glucagon multiagonist can shift receptor potency balance by orders of magnitude, selectively suppress β-arrestin recruitment, or …
Stapling LRRK2
Kennedy Lab
Hydrocarbon-stapled peptides that mimic the C-terminal helix of LRRK2 can penetrate cells, bind the kinase directly, and suppress its hyperactivation without triggering the mislocalization side …
Hairpins Hold the Key
Hall, Radford, and Brockwell Labs
A single methionine swap in α-synuclein's N-terminal P1 motif dismantles the β-hairpin architecture that normally launches amyloid fibril formation
Silencing Strep Signals
Tal-Gan Lab
Streptococcus sinensis is an oral commensal that turns deadly when it reaches the bloodstream, causing infective endocarditis with roughly 25% mortality. A new mutational map …
Fragment Capping PDZ
Wilson Lab
β-strand-mediated protein–protein interactions are among the hardest targets in chemical biology, and PDZ domains are notoriously resistant to small-molecule ligands. A dynamic ligation screen against …
Stabilizing SNEW
Sawyer Lab
The EphB2 receptor drives several cancers, yet its best peptide inhibitor, SNEW, has languished with modest potency and poor serum stability. Swapping its N-terminal serine …
Priming the Attack
Kimmel Lab
No peptide cancer vaccine has yet earned FDA approval, yet the field is converging on strategies that may finally close that gap. A new review …
Peptides on Demand
Chatterjee Lab
Antibodies dominate biochemical research, but their context-dependent performance, reproducibility problems, and opaque binding determinants leave scientists wanting better tools. A new review from the Chatterjee …
Lighting Up Oligomers
Tonali Lab
A cyclopeptide-BODIPY conjugate built from Alzheimer's own amyloid sequence outperforms antibodies at spotting toxic prefibrillar aggregates inside neurons
Stabilizing Pseudouridimycin
Del Valle Group
Cryo-EM guided solid-phase synthesis yields 50 stabilized pseudouridimycin analogs, including a para-phenyl amidine that inhibits bacterial RNA polymerase fourfold better than the parent compound
Triple Receptor Agonism
DiMarchi Group
An engineered triple agonist targeting FGF21, GLP-1, and GIP receptors achieves near normalization of body weight in obese mice.
Myeloma in Focus
Shokeen Group
Researchers in the Shokeen Group at Washington University in St. Louis, published in Bioconjugate Chemistry, identified a novel CD38-binding peptide sequence, HAPWFRGGGGS, through phage …
Targeting Protein Interactions
Arora Lab
Researchers in the Arora Group at New York University, published in Chemical Reviews, have assembled a comprehensive blueprint for designing inhibitors of protein-protein interactions. …
Metabolic Resilience
Labs at Genentech
Researchers at Genentech, published in the Journal of Medicinal Chemistry, present a comprehensive perspective on the strategies that medicinal chemists and DMPK scientists now …
Selective Protein Degraders
Tang Group
Researchers in the Tang Group at the University of Wisconsin-Madison, in collaboration with colleagues at NovoNordisk, published in Advanced Science, have engineered an insulin-like …
Helical Peptide Discovery
Suga and Katoh Labs
A team led by Hiroaki Suga and Takayuki Katoh at the University of Tokyo extended their engineered tRNA system, tRNAPro1E2, to incorporate five achiral dαAAs …
Supra-Bivalent Inhibitors
Sengoku and Suga Labs
A collaboration between the laboratories of Professor Hiroaki Suga at the University of Tokyo and Professor Toru Sengoku at Yokohama City University has developed a …
Conditional Miniprotein Activation
Oller-Salvia Lab
Protein therapeutics have transformed treatment of diseases from cancer to immune disorders, yet many targets appear not only at diseased sites but also in healthy …
ACE-Inhibitory Peptides
Beys-da-Silva Lab
Hypertension remains the leading cause of premature death worldwide, yet one in five affected adults achieve adequate blood pressure control. Angiotensin-converting enzyme inhibitors represent one …
Mirror-Image Hunters
Denisov/Dijkgraaf Labs
Chemokines make frustrating drug targets. These small signaling proteins orchestrate immune cell migration during inflammation, making them attractive therapeutic targets for conditions ranging from atherosclerosis …